Pediatric Nephrology, published by Springer, is a leading international journal dedicated to advancing the field of pediatric nephrology and enhancing the health of children with renal disorders. With its ISSN 0931-041X and E-ISSN 1432-198X, this esteemed journal has been in circulation since 1987 and has established itself as a vital resource for researchers and clinicians alike. Featuring a robust impact factor and categorized in Q1 for Pediatrics, Perinatology and Child Health, and Q2 for Nephrology, Pediatric Nephrology stands at the forefront of medical literature, reflecting its commitment to disseminating high-quality research. The journal is particularly noted for its comprehensive scope, encompassing clinical studies, innovative treatments, and cutting-edge research findings that shape pediatric kidney care. Located in Germany and reaching a global audience, this journal not only supports the academic community but also plays a crucial role in improving health outcomes for children worldwide. Access to its valuable content is essential for any practitioner or researcher invested in the evolving landscape of pediatric medicine.

Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.

The International Journal of Nephrology and Renovascular Disease is a prestigious peer-reviewed journal dedicated to advancing the field of nephrology and related renal research. Published by DOVE MEDICAL PRESS LTD, this open access journal has been a vital resource for the nephrology community since its inception in 2008. With a focus on innovative studies and emerging trends, the journal has established itself in the scholarly landscape, achieving an impressive Q2 ranking within the nephrology category according to the 2023 Scopus metrics, and positioning itself at rank #33 out of 81 journals in the field. The journal aims to provide a platform for both established researchers and emerging scholars to share their findings and insights, significantly contributing to improving patient outcomes and enhancing the understanding of renal health. As it continuously seeks to publish high-quality research that reflects the latest developments in the discipline, the International Journal of Nephrology and Renovascular Disease serves as an indispensable tool for anyone involved in nephrology research, clinical practice, and education.

NEPHROLOGY is a leading academic journal published by Wiley, dedicated to advancing research and discussions in the fields of Nephrology and Medicine. With an ISSN of 1320-5358, this journal has consistently demonstrated its significance and impact, reflecting a Q2 category ranking in both Medicine (miscellaneous) and Nephrology as of 2023. Covering a comprehensive range of topics since its inception in 1995, NEPHROLOGY provides a vital platform for researchers, practitioners, and students alike to explore the latest advancements, innovative treatments, and diverse challenges within the field. Although it does not operate under an open access model, the journal remains highly regarded, with a commendable Scopus rank of #27 out of 81 in Nephrology, positioning it in the 67th percentile among its peers. Located in the United Kingdom, NEPHROLOGY invites submissions that push the boundaries of knowledge, ultimately striving to enhance the understanding of renal health and disease.

NEPHRON is a premier peer-reviewed academic journal dedicated to advancing the field of nephrology and renal medicine. Published by KARGER, renowned for its commitment to quality research, NEPHRON serves as a vital resource for researchers, clinicians, and students interested in the latest findings and developments in kidney health. With an ISSN of 1660-8151 and an E-ISSN of 2235-3186, the journal ensures wide accessibility and dissemination of knowledge in the renal domain. Although specific impact metrics such as the HIndex are presently unavailable, NEPHRON's emphasis on Open Access publishing greatly enhances its visibility and accessibility, allowing groundbreaking research to reach a global audience. Through a comprehensive scope that encompasses clinical studies, basic research, and translational science, NEPHRON contributes significantly to the understanding and treatment of kidney diseases. Join the vibrant community of professionals and scholars who are shaping the future of nephrology by engaging with the wealth of knowledge presented in NEPHRON.

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

ADVANCES IN CHRONIC KIDNEY DISEASE is a pivotal journal in the field of nephrology, published by W B Saunders Co-Elsevier Inc., that has been influential in disseminating cutting-edge research from 2004 until 2022. With an impact factor reflecting its esteem in the academic community and a commendable Q2 ranking within the category of Nephrology, this journal is recognized for its contribution to advancing the understanding of chronic kidney disease. Although the journal's coverage in Scopus has been discontinued, it maintains a key position, holding the 13th rank out of 70 in the Nephrology medicine classification, showcasing its prominent percentile of 82. Subscribers to the journal can look forward to a repository of high-quality articles and reviews that explore novel therapeutic approaches, epidemiological studies, and potential biomarkers in chronic kidney disease, making it a vital resource for researchers, professionals, and students striving to enhance their knowledge and practice in nephrology. For more information on accessing issues or viewing title changes, please refer to the journal's official page.

Nature Reviews Nephrology is a prestigious academic journal published by NATURE PORTFOLIO, focusing on the rapidly evolving field of nephrology. As a leader in its category, it holds an impressive Q1 ranking in the 2023 category for Nephrology and ranks #1 out of 81 in the Scopus metrics, reflecting its high impact and relevance within the scientific community, with a staggering 99th percentile ranking. Established in 2009, this journal provides in-depth reviews, critical analysis, and cutting-edge research updates, making it an essential resource for researchers, professionals, and students alike. With an accessible Open Access policy, it enhances the dissemination of knowledge, ensuring that vital research in renal health and disease reaches a wide audience. Situated in the United Kingdom, Nature Reviews Nephrology remains committed to advancing understanding and treatment in nephrology, emphasizing the importance of this area of study in improving patient outcomes globally.

RENAL FAILURE is a distinguished academic journal published by TAYLOR & FRANCIS LTD, focusing on pivotal research in the fields of nephrology, critical care, and intensive care medicine. With an impact factor reflecting its significant contribution to the medical community, this open access journal has been providing a platform for peer-reviewed articles since its inception, offering free visibility to cutting-edge research since 2016. Based in the United Kingdom, RENAL FAILURE is essential for professionals, researchers, and students who seek to stay informed about the latest advancements and clinical practices in renal care. The journal’s Scopus ranking places it among the top-tier publications in its category, boasting a Q2 ranking in critical care, general medicine, and nephrology, underscoring its impactfulness in the global research landscape. Catering to a wide audience, it spans literature from 1976 through 2024, making it a cornerstone resource for anyone dedicated to enhancing the understanding and treatment of renal diseases.